Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.
Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. Dodd S, et al. Among authors: copolov dl. Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. Expert Opin Biol Ther. 2008. PMID: 18990082 Review.
Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial.
Bernardo M, Dodd S, Gama CS, Copolov DL, Dean O, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI, Berk M. Bernardo M, et al. Among authors: copolov dl. Acta Neuropsychiatr. 2009 Oct;21(5):239-45. doi: 10.1111/j.1601-5215.2009.00415.x. Acta Neuropsychiatr. 2009. PMID: 26952771
Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial.
Bernardo M, Dodd S, Gama CS, Copolov DL, Dean O, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI, Berk M. Bernardo M, et al. Among authors: copolov dl. Acta Neuropsychiatr. 2009 Dec;21(6):285-91. doi: 10.1111/j.1601-5215.2009.00397.x. Acta Neuropsychiatr. 2009. PMID: 25384734
Effects of N-acetyl cysteine on cognitive function in bipolar disorder.
Dean OM, Bush AI, Copolov DL, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M. Dean OM, et al. Among authors: copolov dl. Psychiatry Clin Neurosci. 2012 Oct;66(6):514-7. doi: 10.1111/j.1440-1819.2012.02392.x. Psychiatry Clin Neurosci. 2012. PMID: 23066769 Free article. Clinical Trial.
A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.
Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M. Dean OM, et al. Among authors: copolov dl. Curr Med Chem. 2009;16(23):2965-76. doi: 10.2174/092986709788803060. Curr Med Chem. 2009. PMID: 19689277 Review.
The clinical use of plasma clozapine levels.
Bell R, McLaren A, Galanos J, Copolov D. Bell R, et al. Among authors: copolov d. Aust N Z J Psychiatry. 1998 Aug;32(4):567-74. doi: 10.3109/00048679809068332. Aust N Z J Psychiatry. 1998. PMID: 9711372 Review.
Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia.
Dean OM, Mancuso SG, Bush AI, Copolov D, Do KQ, Cuénod M, Conus P, Rossell SL, Castle DJ, Berk M. Dean OM, et al. Among authors: copolov d. Psychiatry Res. 2015 Dec 30;230(3):982-3. doi: 10.1016/j.psychres.2015.10.037. Epub 2015 Nov 2. Psychiatry Res. 2015. PMID: 26626948 No abstract available.
N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.
Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI. Berk M, et al. Among authors: copolov d. Biol Psychiatry. 2008 Sep 1;64(5):361-8. doi: 10.1016/j.biopsych.2008.03.004. Epub 2008 Apr 23. Biol Psychiatry. 2008. PMID: 18436195 Clinical Trial.
N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
Dean OM, van den Buuse M, Berk M, Copolov DL, Mavros C, Bush AI. Dean OM, et al. Among authors: copolov dl. Neurosci Lett. 2011 Jul 25;499(3):149-53. doi: 10.1016/j.neulet.2011.05.027. Epub 2011 May 20. Neurosci Lett. 2011. PMID: 21621586
Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice.
Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M. Dean O, et al. Among authors: copolov dl. Pharmacol Biochem Behav. 2010 Dec;97(2):293-300. doi: 10.1016/j.pbb.2010.08.013. Epub 2010 Sep 9. Pharmacol Biochem Behav. 2010. PMID: 20816888
121 results
Jump to page
Feedback